Apollo Hospital Ent. Key Ratios

The PAT margin has seen a decline from 7.2% in 2022 to 4.7% in 2024, significantly impacting ROE especially in 2023 and 2024. The asset turnover ratio remains stable, indicating consistent efficiency in using assets for generating sales, averaging around 1.09 during the analyzed period. Leverage has decreased slightly but remains high, suggesting that while equity returns are pressured by profitability, the company still relies on debt to boost its ROE.

Inventory days have improved slightly from 9.03 in 2023 to 7.88 in 2025, indicating more efficient stock management. However, receivable days have increased consistently, from 38.53 in 2022 to 46.32 in 2025, suggesting slower collections which could worsen cash flow. Payable days also increased, indicating that the company is taking longer to pay its suppliers, thus extending its cash conversion cycle but maintaining a negative value throughout the years.

ROE has fluctuated significantly, achieving peaks of 21.6% and dropping to 14.3% before rebounding, influenced primarily by declines in PAT margin. ROCE has similarly trended due to the intensified impact of debt usage alongside variations in net profit, indicating that while overall returns are pressured, capital efficiency remains a bit more stable. ROA demonstrates a consistent drop with only a slight recovery in 2025, highlighting that overall asset efficiency has weakened, limiting broad-based financial performance.